SELLAS Life Sciences announces settlement of counterclaims against JGB (Cayman)
SELLAS Life Sciences announced a settlement with JGB (Cayman) regarding Sellas' counterclaims against JGB which were asserted in the litigation originally commenced by JGB. As part of the settlement, JGB has paid SELLAS approximately $6.6 million in exchange for a full discharge of all claims. November 09, 2018